Page last updated: 2024-09-05

l 680833 and calcimycin

l 680833 has been researched along with calcimycin in 1 studies

Compound Research Comparison

Studies
(l 680833)
Trials
(l 680833)
Recent Studies (post-2010)
(l 680833)
Studies
(calcimycin)
Trials
(calcimycin)
Recent Studies (post-2010) (calcimycin)
50011,94640444

Protein Interaction Comparison

ProteinTaxonomyl 680833 (IC50)calcimycin (IC50)
XBP1Homo sapiens (human)1.41
DNA damage-inducible transcript 3 proteinMus musculus (house mouse)0.16

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brause, K; Chandler, GO; Doherty, JB; Dorn, CP; Finke, PE; Hagmann, WK; Hale, JJ; Kissinger, AL; Shah, SK; Thompson, KR1

Other Studies

1 other study(ies) available for l 680833 and calcimycin

ArticleYear
Chemical, biochemical, pharmacokinetic, and biological properties of L-680,833: a potent, orally active monocyclic beta-lactam inhibitor of human polymorphonuclear leukocyte elastase.
    Proceedings of the National Academy of Sciences of the United States of America, 1993, Sep-15, Volume: 90, Issue:18

    Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; beta-Lactams; Biological Availability; Calcimycin; Cricetinae; Fibrinogen; Hemorrhage; Humans; Lactams; Leukocyte Elastase; Lung Diseases; Macaca mulatta; Mice; Molecular Sequence Data; Molecular Structure; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pancreatic Elastase; Peptide Fragments; Phenylacetates; Rats; Structure-Activity Relationship

1993
chemdatabank.com